Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

6 treatments under study, led by Elastikon

Research Leaders

5 sponsors active, led by Institut de Formation et de Recherche en Médecine de Montagne

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 15/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

4Total
Not Applicable (3)
Phase 3 (1)

Trial Status

Unknown3
Completed1
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (5)

Showing 5 of 5 trials
NCT07807904Phase 3Not Yet RecruitingPrimary

NanoSALV vs Standard Topical Care Pathway in Sports-Related Skin Lesions

NCT05086640Not ApplicableUnknownPrimary

Evaluation of the Effectiveness of the Local Application of Lemon in the Prevention of Blisters in Ultra-trail Runners

NCT05071651Unknown

Epidemiological Characteristics and Prevention Methods of Blisters in Ultra-trail Runners

NCT03835806Not ApplicableUnknownPrimary

Blister Eradication Looking at Impact of Experimental Versus Established Regimens

NCT01945112Not ApplicableCompletedPrimary

Prevention Trial Assessing Paper-Tape in Endurance Distances II (Pre-TAPED II)

Showing all 5 trials

Research Network

Common Treatments

  • Elastikon1
  • Rocktape1
  • Standard Topical Care Pathway1
  • Nanosalv Catalytic1
  • Paper Tape1

Active Sponsors

  • Institut de Formation et de Recherche en Médecine de Montagne2
  • Stanford University2
  • Shahab Alizadeh1
  • Canadian Sport Institute Alberta1
  • Resurrection Medical Center1

Top Investigators

Related Conditions

  • Sport Injury2
  • Blister1

Activity Timeline